Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Jupiter Life Line Hospitals
Mid Cap•2,828 Employees•IPO 2023
Current Price
₹1291.20
17.9 (1.41%)Updated
Today's Range
₹1242.60
₹1299.00
₹1291.20
52 Week Range
52W Low₹1198.80
52W High₹1770.00
₹1291.20
Downside7.71%
Upside37.08%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹8,107.57 Cr
Market Cap
Total market value of companyP/E Ratio
42.83
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
6.87
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹28.77
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
7.28%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
18.00%
ROCE
Return on Capital Employed. >15% is goodNet Margin
13.16%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
45.56%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
22.20%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
20.50%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-1.42%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.29
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹206.85
Book Value
Net asset value per shareDividend Yield
0.08%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
40.90%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •Jupiter Life Line Hospitals Ltd exhibits a strong Return on Equity (ROE) of 15%, indicating efficient utilization of shareholder investments and promising profitability. This, coupled with a healthy Operating Profit Margin (OPM) of 23.30%, showcases effective cost management and operational efficiency within the healthcare sector.
- •Jupiter Life Line Hospitals shows consistent quarterly sales growth of 20.5%, indicating strong demand and market position. A robust Return on Capital Employed (ROCE) of 18% further highlights efficient capital allocation and operational effectiveness.
Weaknesses
4 points- •Jupiter Life Line Hospitals' high Price-to-Earnings (P/E) ratio of 53.30 suggests potential overvaluation compared to its earnings. Investors should carefully assess this metric, especially given current market volatility, before making investment decisions.
- •Promoter holding at 40.9% leaves a significant portion of shares in public hands. This could potentially increase stock price volatility due to market sentiment and speculative trading, warranting investor caution regarding ownership concentration.
Opportunities
3 points- •The healthcare sector, especially hospitals, is set for significant growth, driven by rising health awareness, an aging population, and expanding medical tourism. This trend offers substantial market expansion opportunities for Jupiter Life Line Hospitals.
- •Increasing FII holdings from 4.62% to 9.06% and DIIs from 12.69% to 16.97% since Sept 2023 signals growing institutional confidence. This positive trend could attract further investment and potentially boost the company's stock valuation.
Threats
3 points- •The hospital industry is highly competitive, with established players like Apollo Hospitals and Max Healthcare dominating. Intense competition could pressure Jupiter Life Line Hospitals' margins and market share, impacting future profitability.
- •The healthcare sector faces stringent and evolving regulatory frameworks. Adverse changes in government policies, pricing controls, or insurance reimbursement norms could significantly impact Jupiter Life Line Hospitals' operational costs and revenue.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1425.40 | +₹134.20 | +10.39% |
| R3 | ₹1369.00 | +₹77.80 | +6.03% |
| R2 | ₹1334.00 | +₹42.80 | +3.31% |
| R1 | ₹1312.60 | +₹21.40 | +1.66% |
| PIVOT | ₹1277.60 | -13.60 | -1.05% |
| CURRENT | ₹1291.20 | - | - |
| S1 | ₹1143.40 | -₹147.80 | -11.45% |
| S2 | ₹1199.80 | -₹91.40 | -7.08% |
| S3 | ₹1221.20 | -₹70.00 | -5.42% |
| S4 | ₹1256.20 | -₹35.00 | -2.71% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+5.6% vs avg
0.19L
(04 Mar 2026)Delivery %-4.7% vs avg
44.4%
(04 Mar 2026)Avg Volume (20D)20-day average
0.18L
(04 Feb - 04 Mar)Avg Delivery %Trend ↓
49.1%
(04 Feb - 04 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
Indraprastha Medical Corporation Ltd
1.13 %
Peer Comparison
| Company Name |
|---|
 Dr Agarwals Health Care Ltd |
 Apollo Hospitals Enterprise Ltd |
 Artemis Medicare Services Ltd |
 Aster DM Healthcare Ltd |
 Healthcare Global Enterprises Ltd |
 Indraprastha Medical Corporation Ltd |
 |
 Krishna Institute of Medical Sciences Ltd |
 Global Health Ltd |
 Rainbow Childrens Medicare Ltd |
 Shalby Ltd |
 Yatharth Hospital & Trauma Care Services Ltd |
About
Jupiter Life Line Hospitals Ltd
Jupiter Life Line Hospitals Limited (JLHL) is a multi-specialty healthcare provider operating in India under the Jupiter brand. Its core business is the delivery of a wide range of medical services across numerous specialties. This comprehensive approach allows them to cater to a diverse patient population requiring various levels of care.
The hospital's services span a considerable spectrum of medical disciplines. These include, but are not limited to, cardiology and cardiac surgery, oncology, orthopedics (including robotic knee replacement and robotic surgery), neurosurgery, gastroenterology, and a comprehensive range of surgical procedures (general, bariatric, minimal access, and HPB surgical gastroenterology). They also offer specialized care in areas such as organ transplantation, interventional radiology, and mental health.
Beyond surgical and procedural interventions, JLHL provides a substantial array of diagnostic and therapeutic services. These include internal medicine, endocrinology and diabetes care, nephrology, neurology, and rheumatology. Support services such as diagnostic imaging, laboratory testing, and rehabilitation are integral components of their holistic patient care model. Additionally, the hospital offers specialized centers, such as breast care, dental care, and a pain clinic.
In addition to its core healthcare operations, JLHL demonstrates diversification through its ownership of a hotel, the Fortune Park Lake City Hotel in Thane. While this venture is distinct from its primary healthcare focus, it potentially contributes to the overall financial stability and operational infrastructure of the company. This diversification strategy may also serve to attract medical tourists or provide convenient accommodation for patients and their families.
Established in 2002 and headquartered in Mumbai, JLHL has positioned itself as a significant player in the Indian healthcare landscape. Its broad service offerings, combined with its multi-specialty approach, aim to provide comprehensive medical care under one roof. The inclusion of the hotel suggests a business model that aims to go beyond pure healthcare provision to create a more integrated patient experience.
COMPANY FACTS - JLHL
Registered Address
Eastern Express Highway, Service Rd, Next To Viviana Mall
Thane
MAHARASHTRA
IN
Tel: 912262975555
Website:https://www.jupiterhospital.com
Investor Relations:http://www.jupiterhospital.com/investor-relations/
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 2,828
IPO Date: 18/09/2023
MANAGEMENT - JLHL
Dr. Ajay Thakker
Executive Chairman of the Board, Managing Director
Dr. Ankit Thakker
Chief Executive Officer, Executive Director
Mr. Harshad Purani
Chief Financial Officer, President - Administration, Head - Corporate Social Responsibility
Dr. Rajendra Patankar
Chief Executive Officer of Pune Hospital
Dr. Shilpa Tatake
Corporate Chief Operating Officer
Ms. Manisha Shah
Group Chief Human Resource Officer
Mrs. Suma Upparatti
Compliance Officer, Company Secretary
Mr. Pradip Acharya
Head - Corporate Relations
Mr. Anand Apte
Chief Business and Strategy Officer
Mr. Sumit Goda
Corporate Head - Supply Chain and CPU
Mr. Neelesh Shinde
Group Chief Technical Officer
Mr. Vadapatra Raghavan
Non-Executive Director
Investor Questions Answered
Jupiter Life Line Hospitals Ltd (JLHL) Stock FAQs
Get answers to the most common questions about Jupiter Life Line Hospitals Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Jupiter Life Line Hospitals Ltd (JLHL) is ₹1,291.2. Today, the stock has gained by ₹17.90 (1.41%), trading in a range of ₹1,242.6 to ₹1,299. The stock opened at ₹1,280 with a trading volume of 19,056 shares.
Jupiter Life Line Hospitals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹8,107.57 crores, P/E ratio of 42.83, ROE of 7.28%, and ROCE of 18.00%. The dividend yield stands at 0.08%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Jupiter Life Line Hospitals Ltd (JLHL) is ₹1,770, while the 52-week low is ₹1,198.8. Currently trading at ₹1,291.2, the stock is 16.2% away from its 52-week low and 27.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Jupiter Life Line Hospitals Ltd stock at ₹1,291.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 42.83 and P/B ratio of N/A. Today's performance shows a gain of 1.41%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Jupiter Life Line Hospitals Ltd offers a dividend yield of 0.08%, which means for every ₹100 invested at the current price of ₹1,291.2, you can expect to receive approximately ₹0.08 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Jupiter Life Line Hospitals Ltd's key financial metrics include: P/E Ratio: 42.83, P/B Ratio: N/A, ROE: 7.28%, ROCE: 18.00%, Dividend Yield: 0.08%, EPS: ₹28.77, Book Value: ₹206.85, Debt-to-Equity: 0.29, and Current Ratio: N/A. The company's market cap stands at ₹8,107.57 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Jupiter Life Line Hospitals Ltd stock opened at ₹1,280 and is currently trading at ₹1,291.2, showing a gain of ₹17.90 (1.41%). The intraday high is ₹1,299 and low is ₹1,242.6. The trading volume stands at 19,056 shares, indicating moderate market participation today.
Jupiter Life Line Hospitals Ltd has a Price-to-Earnings (P/E) ratio of 42.83, which means investors are willing to pay ₹42.83 for every ₹1 of earnings. With an EPS of ₹28.77, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Jupiter Life Line Hospitals Ltd has a market capitalization of ₹8,107.57 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,291.2) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Jupiter Life Line Hospitals Ltd has a book value of ₹206.85 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,291.2, which is 524.2% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Jupiter Life Line Hospitals Ltd has a Return on Equity (ROE) of 7.28% and Return on Capital Employed (ROCE) of 18.00%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Jupiter Life Line Hospitals Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Jupiter Life Line Hospitals Ltd has a debt-to-equity ratio of 0.29, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Jupiter Life Line Hospitals Ltd has an Earnings Per Share (EPS) of ₹28.77, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,291.2 and P/E ratio of 42.83, investors are paying 42.83 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
Jupiter Life Line Hospitals Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Jupiter Life Line Hospitals Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Jupiter Life Line Hospitals Ltd stock, consider: 1) Fundamental Analysis - Review P/E (42.83), ROE (7.28%), debt-to-equity (0.29), and growth rates. 2) Technical Analysis - Check 52-week range (₹1198.80 - ₹1770.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1291.20) with book value (₹206.85) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Jupiter Life Line Hospitals Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,291.2 is 12812x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Jupiter Life Line Hospitals Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹1198.80 - ₹1770.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.29 indicates leverage. 4) Liquidity Risk - Based on trading volume of 19,056 shares. 5) Valuation Risk - P/E of 42.83 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Jupiter Life Line Hospitals Ltd operates in the industry with key metrics: P/E ratio of 42.83, ROE of 7.28%, market cap of ₹8,107.57 crores, and dividend yield of 0.08%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.29), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Jupiter Life Line Hospitals Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,291.2, with a 52-week range of ₹1198.80 to ₹1770.00. Based on fundamentals like P/E (42.83), ROE (7.28%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Jupiter Life Line Hospitals Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1291.20. 2) Fundamental Deterioration - Declining ROE (currently 7.28%), increasing debt (D/E: 0.29), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Jupiter Life Line Hospitals Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.08%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu